Alegro appoints Peter Walkey as Chief Financial Officer



    TORONTO, May 14 /CNW/ - Alegro Health Corp. (TSX-V: AGO), a provider of
medical, surgical and disability management services, today announced that it
has appointed Peter Walkey to the position of Chief Financial Officer.
    "With his extensive financial management and public markets experience,
Peter is a perfect addition to Alegro's executive team," said Brenda
Rasmussen, President and Chief Executive Officer of Alegro. "His addition
solidifies a strong management team while we build on the momentum of our
recent acquisition of Active Health Management and continue to pursue our goal
of becoming Canada's leading healthcare services provider."
    Mr. Walkey joins Alegro with over 15 years of senior financial management
and merger and acquisition experience. Mr. Walkey was previously Chief
Financial Officer of TSX listed Priszm Income Fund, prior to which he was
Chief Financial Officer of Yum! Restaurants Canada. Throughout his career, Mr.
Walkey has held various executive financial management positions. Mr. Walkey
is a Certified General Accountant, attended the Queen's University Leadership
Development program and holds a Bachelor's of Commerce degree from the
University of Toronto.
    Concurrent with his appointment, Alegro granted Mr. Walkey 500,000 stock
options on May 14, 2009 pursuant to the Corporation's 2008 Stock Option Plan.
The stock options were issued at an exercise price of $0.39 and expire May 14,
2014.

    About Alegro Health Corp.

    Alegro Health Corp. is a leading healthcare services provider capturing
high value opportunities by providing additional access to select quality
healthcare services. Through its divisions - Disability & Rehabilitation
Management and Surgical/Hospital Services - Alegro is delivering additional
resources to the Canadian public healthcare services and addressing the
growing demand for private and enhanced out-of-pocket healthcare services.
With superior knowledge of the healthcare industry, extensive and trusted
relationships with payers, physicians, and government agencies, Alegro is
pursuing a vertically integrated approach and an aggressive acquisition
strategy to achieve its growth objectives. Alegro is listed on the TSX Venture
Exchange under the symbol AGO. For further information, please visit
www.alegrohealth.com.

    This press release contains statements that may constitute
"forward-looking statements" within the meaning of applicable Canadian
securities legislation. These forward-looking statements include, among
others, statements regarding business strategy, plans and other expectations,
beliefs, goals, objectives, information and statements about possible future
events. Specific forward-looking statements contained in this press release
include statements regarding Alegro's proposed acquisition of Active Health,
the completion of the acquisition and the outcome of the acquisition, as well
as statements regarding transaction values, accretion, and ownership levels
resulting from the completion of the proposed acquisition. Readers are
cautioned not to place undue reliance on such forward-looking statements.
Forward-looking statements are based on current expectations, estimates and
assumptions that involve a number of risks, which could cause actual results
to vary and in some instances to differ materially from those anticipated by
Alegro and Active Health and described in the forward-looking statements
contained in this press release. Among the various factors that could cause
results to vary materially from those indicated in the forward-looking
statements include failure to realize anticipated synergies and the result of
the review of the proposed acquisition by regulatory authorities. No assurance
can be given that any of the events anticipated by the forward-looking
statements will transpire or occur or, if any of them do so, what benefits
Alegro will derive there from.

    
    This release was prepared by management of the Company who takes full
    responsibility for its contents. The TSX Venture Exchange has not
    reviewed and does not accept responsibility for the adequacy or accuracy
    of this news release.
    

    %SEDAR: 00016656E




For further information:

For further information: Brenda Rasmussen, President and CEO, Alegro
Health, (416) 927-8400 ext. 303, brasmussen@alegrohealth.com; Michael Moore,
Investor Relations, Equicom Group, (416) 815-0700 ext. 241,
mmoore@equicomgroup.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890